|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2
|
Rapp E, Pater JL, Willan A, et al:
Chemotherapy can prolong survival in patients with advanced
non-small cell lung cancer - report of a Canadian multicenter
randomized trial. J Clin Oncol. 6:633–641. 1988.PubMed/NCBI
|
|
3
|
Grilli R, Oxman AD and Julian JA:
Chemotherapy for advanced non-small cell lung cancer: how much
benefit is enough? J Clin Oncol. 11:1866–1872. 1993.PubMed/NCBI
|
|
4
|
Cullen MH, Billingham LJ, Woodroffe CM, et
al: Mitomycin, ifosfamide, and cisplatin in unresectable non-small
cell lung cancer: effects on survival and quality of life. J Clin
Oncol. 17:3188–3194. 1999.PubMed/NCBI
|
|
5
|
Schiller JH, Harrington D, Belani CP, et
al: Comparison of four chemotherapy regimens for advanced non-small
cell lung cancer. N Engl J Med. 346:92–98. 2002. View Article : Google Scholar
|
|
6
|
Belani CP and Langer C: First-line
chemotherapy for NSCLC: an overview of relevant trials. Lung
Cancer. 38(Suppl 4): 13–19. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang SC: BAG-1, an anti-apoptotic tumour
marker. IUBMB Life. 53:99–105. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Townsend PA, Cutress RI, Sharp A, Brimmell
M and Packham G: BAG-1: a multifunctional regulator of cell growth
and survival. Biochim Biophys Acta. 1603:83–98. 2003.PubMed/NCBI
|
|
9
|
Liman J, Faida L, Dohm CP, Reed JC, Bahr M
and Kermer P: Subcellular distribution affects BAG1 function. Brain
Res. 1198:21–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cutress RI, Townsend PA, Brimmell M,
Bateman AC, Hague A and Packham G: BAG-1 expression and function in
human cancer. Br J Cancer. 87:834–839. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rorke S, Murphy S, Khalifa M, Chernenko G
and Tang SC: Prognostic significance of BAG-1 expression in
non-small cell lung cancer. Int J Cancer. 95:317–322. 2001.
View Article : Google Scholar
|
|
12
|
Gautschi O, Hugli B, Ziegler A, et al:
Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced
lung cancer risk and response to platinum-based chemotherapy in
non-small cell lung cancer (NSCLC) patients. Lung Cancer.
51:303–311. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shih CM, Lee YL, Chiou HL, et al:
Association of TNF-alpha polymorphism with susceptibility to and
severity of non-small cell lung cancer. Lung Cancer. 52:15–20.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang S, Jin X, Wang R, et al:
Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung
carcinoma in North China. Carcinogenesis. 26:481–486. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Humphray SJ, Oliver K, Hunt AR, et al: DNA
sequence and analysis of human chromosome 9. Nature. 429:369–374.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Silvestrini R, Costa A, Lequaglie C, et
al: Bcl-2 protein and prognosis in patients with potentially
curable non-small cell lung cancer. Virchows Arch. 432:441–444.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dosaka-Akita H, Katabami M, Hommura H,
Fujioka Y, Katoh H and Kawakami Y: Bcl-2 expression in non-small
cell lung cancers: higher frequency of expression in squamous cell
carcinomas with earlier pT status. Oncology. 56:259–264. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mitsudomi T, Hamajima N, Ogawa M and
Takahashi T: Prognostic significance of p53 alterations in patients
with non-small cell lung cancer: a meta-analysis. Clin Cancer Res.
6:4055–4063. 2000.PubMed/NCBI
|
|
19
|
Takayama S, Sato T, Krajewski S, et al:
Cloning and functional analysis of BAG-1: a novel Bcl-2-binding
protein with anti-cell death activity. Cell. 80:279–284. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takayama S and Reed JC: Molecular
chaperone targeting and regulation by BAG family proteins. Nat Cell
Biol. 3:E237–E241. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hohfeld J: Regulation of the heat shock
conjugate Hsc70 in the mammalian cell: the characterization of the
anti-apoptotic protein BAG-1 provides novel insights. Biol Chem.
379:269–274. 1998.PubMed/NCBI
|
|
22
|
Millar EK, Anderson LR, McNeil CM, et al:
BAG-1 predicts patient outcome and tamoxifen responsiveness in
ER-positive invasive ductal carcinoma of the breast. Br J Cancer.
100:123–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nadler Y, Camp RL, Giltnane JM, et al:
Expression patterns and prognostic value of Bag-1 and Bcl-2 in
breast cancer. Breast Cancer Res. 10:R352008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu H, Bai Y, Liu B, et al: The expression
of BAG-1 and its clinical significance in human lung cancer.
Zhongguo Fei Ai Za Zhi. 11:489–494. 2008.(In Chinese).
|
|
25
|
Tormanen U, Eerola AK, Rainio P, et al:
Enhanced apoptosis predicts shortened survival in non-small cell
lung carcinoma. Cancer Res. 55:5595–5602. 1995.PubMed/NCBI
|
|
26
|
Takahashi N, Yanagihara M, Ogawa Y,
Yamanoha B and Andoh T: Down-regulation of Bcl-2-interacting
protein BAG-1 confers resistance to anti-cancer drugs. Biochem
Biophys Res Commun. 301:798–803. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Clemo NK, Collard TJ, Southern SL, et al:
BAG-1 is up-regulated in colorectal tumour progression and promotes
colorectal tumour cell survival through increased NF-kappaB
activity. Carcinogenesis. 29:849–857. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Wang B and Li SN: Advances in the
research of single nucleotide polymorphism. J Yunan Normal
University (Natural Sciences Edition). 27:40–44. 2007.
|
